First stages of alzheimer's
Pro Research Analysisby 
Searched over 200M research papers
Understanding the First Stages of Alzheimer's Disease
Introduction to Preclinical Alzheimer's Disease
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that begins long before the onset of clinical symptoms. This early phase, known as the preclinical stage, offers a critical window for potential therapeutic intervention Sperling2011Dubois2016. The National Institute on Aging and the Alzheimer's Association have developed guidelines to identify and study these early stages, emphasizing the importance of biomarkers and neuropsychological evidence .
Biomarkers and Early Detection
Amyloid and Tau Pathology
The hallmark pathologies of AD include extracellular amyloid-beta (Aβ) deposits and intraneuronal tau tangles. Initial amyloid deposits typically appear in the basal neocortex and spread to other cortical areas and the hippocampus, while tau pathology begins in the transentorhinal region and progresses predictably across the brain Braak1997Braak2011. These pathological changes can be detected using advanced imaging techniques and biomarkers, which are crucial for identifying individuals in the preclinical stages of AD Braak2011Lopez2019.
Subjective Cognitive Decline (SCD)
Subjective cognitive decline (SCD) is often the first noticeable symptom in the preclinical stage of AD. Individuals with SCD report memory issues despite performing normally on cognitive tests. This stage is significant as it precedes mild cognitive impairment (MCI) and full-blown AD Yan2019Kiselica2021. Studies have shown that individuals with positive amyloid biomarkers and SCD are at a higher risk of progressing to more severe stages of AD Kiselica2020Kiselica2021.
Staging Preclinical Alzheimer's Disease
Stages 1 and 2 of the Alzheimer's Continuum
The Alzheimer's continuum (AC) is divided into several stages, with stages 1 and 2 representing the preclinical phase. Stage 1 is characterized by the presence of amyloid biomarkers without any clinical symptoms, while stage 2 includes amyloid biomarkers along with evidence of neurodegeneration and subtle cognitive changes Kiselica2021Knopman2012. These stages are crucial for research as they help in understanding the progression of the disease and identifying potential intervention points.
Empirical Operationalization
Research has empirically defined these stages by examining cognitively normal individuals with known amyloid status. Findings indicate that transitional cognitive decline is more frequent among amyloid-positive individuals, suggesting that the presence of two symptom classes (subjective cognitive complaints and neurobehavioral symptoms) provides a good balance for defining early stages of the AC .
Pathological Development and Age
Age-Related Progression
AD is an age-related disease, with the prevalence of amyloid and tau pathologies increasing with age. However, the initial stages of these pathologies can occur independently of age, indicating that advanced age is not a prerequisite for the development of AD lesions Braak1997Braak2011. Early detection and understanding of these pathologies are essential for developing effective interventions.
Atrophy Patterns
Different clinical variants of AD show distinct atrophy patterns in the brain. For instance, early-stage atrophy in the posterior cortical atrophy (PCA) variant affects visual networks, while the logopenic variant primary progressive aphasia (lvPPA) impacts language networks. These patterns highlight the importance of targeted diagnostic approaches for different AD phenotypes .
Conclusion
The first stages of Alzheimer's disease, characterized by amyloid and tau pathologies, subjective cognitive decline, and subtle neurodegenerative changes, offer a critical window for early intervention. Understanding these preclinical stages through biomarkers and neuroimaging can pave the way for developing effective therapies to slow or halt the progression of AD. Continued research in this area is essential for improving early diagnosis and treatment outcomes.
Sources and full results
Most relevant research papers on this topic